Induction interferon therapy in naïve patients with chronic hepatitis C: increased end-of-treatment virological responses but absence of long-term benefit
- 1 April 2001
- journal article
- clinical trial
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 15 (4) , 551-557
- https://doi.org/10.1046/j.1365-2036.2001.00946.x
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Reinforced regiment of interferon alfa-2a reduces the incidence of cirrhosis in patients with chronic hepatitis C: a multicentre randomized trialJournal of Hepatology, 1998
- Natural history of hepatitis CHepatology, 1997
- Recombinant interferon‐α‐2a for treatment of chronic hepatitis C: results of a multicenter randomized controlled dose studyLiver International, 1997
- Early indicators of prognosis in fulmitant hepatic failure: an assessment of the King's criteriaJournal of Hepatology, 1997
- Effective administration methods and dosages of interferon therapy for chronic hepatitis CClinical Therapeutics, 1996
- Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivoHepatology, 1996
- Interferon alfa-2b for chronic hepatitis C: effects of dose increment and duration of treatment on response ratesJournal of Hepatology, 1995
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995
- Subclinical hepatic encephalopathy: the diagnostic value of evoked potentialsJournal of Hepatology, 1995
- Hepatitis C virus infection in Greece and its role in chronic liver disease and hepatocellular carcinomaJournal of Hepatology, 1993